Related references
Note: Only part of the references are listed.Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
Joachim Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Bone marrow Th17 TNFα cells induce osteoclast differentiation, and link bone destruction to IBD
Thomas Ciucci et al.
GUT (2015)
Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis Development and Characterization of a Novel Bispecific Antibody
Jens A. A. Fischer et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials
Joachim Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis
Xenofon Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Osteocyte-Driven Bone Remodeling
Teresita Bellido
CALCIFIED TISSUE INTERNATIONAL (2014)
Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus
Jerome C. Martin et al.
CLINICAL IMMUNOLOGY (2014)
Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease
Wenyu Jiang et al.
INFLAMMATION RESEARCH (2014)
Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors
Yoshiya Tanaka et al.
MODERN RHEUMATOLOGY (2014)
Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease
S. Bank et al.
PHARMACOGENOMICS JOURNAL (2014)
Immunopathology of inflammatory bowel disease
Kori L. Wallace et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?
Zana Brkic et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Classical and paradoxical effects of TNF-α on bone homeostasis
Bilal Osta et al.
FRONTIERS IN IMMUNOLOGY (2014)
Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus
Yuko Shirota et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Biologic therapies and systemic bone loss in rheumatoid arthritis
Theodoros Dimitroulas et al.
AUTOIMMUNITY REVIEWS (2013)
Anti-interferon alpha treatment in SLE
Kyriakos A. Kirou et al.
CLINICAL IMMUNOLOGY (2013)
Osteoporosis and vertebral fractures in ankylosing spondylitis
Nicole Davey-Ranasinghe et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Emerging role of interleukin-22 in autoimmune diseases
Hai-Feng Pan et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Dynamic visualization of RANKL and Th17-mediated osteoclast function
Junichi Kikuta et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
Dominique Baeten et al.
LANCET (2013)
Inflammatory bowel disease and the risk of osteoporosis and fracture
Laura E. Targownik et al.
MATURITAS (2013)
Can bone loss in rheumatoid arthritis be prevented?
M. Vis et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Activated NF-κB in Bone Marrow Mesenchymal Stem Cells from Systemic Lupus Erythematosus Patients Inhibits Osteogenic Differentiation Through Downregulating Smad Signaling
Yu Tang et al.
STEM CELLS AND DEVELOPMENT (2013)
Opposing functions of classic and novel IL-1 family members in gut health and disease
Loris R. Lopetuso et al.
FRONTIERS IN IMMUNOLOGY (2013)
Ankylosing Spondylitis: From Cells to Genes
Jose Francisco Zambrano-Zaragoza et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2013)
Large-Scale Analysis of Tumor Necrosis Factor α Levels in Systemic Lupus Erythematosus
Corinna E. Weckerle et al.
ARTHRITIS AND RHEUMATISM (2012)
Therapeutic blockade of TNF in patients with SLE-Promising or crazy?
Martin Aringer et al.
AUTOIMMUNITY REVIEWS (2012)
Autoantibodies in lupus: Culprits or passive bystanders?
Ole P. Rekvig et al.
AUTOIMMUNITY REVIEWS (2012)
Chondrocytic Atf4 regulates osteoblast differentiation and function via Ihh
Weiguang Wang et al.
DEVELOPMENT (2012)
Extracellular matrix protein mediated regulation of the osteoblast differentiation of bone marrow derived human mesenchymal stem cells
Smitha Mathews et al.
DIFFERENTIATION (2012)
Roles of Pro- and Anti-Inflammatory Cytokines in the Pathogenesis of SLE
Ding-Lei Su et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation
Yanqiu Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Inflammatory bone loss: pathogenesis and therapeutic intervention
Kurt Redlich et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Increased Frequencies of Th22 Cells as well as Th17 Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis
Lei Zhang et al.
PLOS ONE (2012)
Osteoporosis and fractures in systemic lupus erythematosus
Irene E. M. Bultink
ARTHRITIS CARE & RESEARCH (2012)
STAT3 is critical to promote inflammatory cytokines and RANKL expression in inflammatory arthritis
Takeshi Miyamoto et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease
S. G. Veerappan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Disorders of Bone Remodeling
Xu Feng et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Interferon-alpha Accelerates Murine Systemic Lupus Erythematosus in a T Cell-Dependent Manner
Zheng Liu et al.
ARTHRITIS AND RHEUMATISM (2011)
Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis
Cheng-Chi Chao et al.
AUTOIMMUNITY (2011)
Expression of POEM, a positive regulator of osteoblast differentiation, is suppressed by TNF-α
Masayuki Tsukasaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis
Yang Mei et al.
CLINICAL RHEUMATOLOGY (2011)
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Markus F. Neurath et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
Toshio Tanaka et al.
FEBS LETTERS (2011)
IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis
Tomoaki Mori et al.
INTERNATIONAL IMMUNOLOGY (2011)
Cell and cytokine imbalances in rheumatoid synovitis
Marie-Christophe Boissier
JOINT BONE SPINE (2011)
Cytokines in Autoimmunity: Role in Induction, Regulation, and Treatment
Kamal D. Moudgil et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus
G. O. Eilertsen et al.
LUPUS (2011)
A role for interleukin-33 in TH2-polarized intestinal inflammation
J. B. Seidelin et al.
MUCOSAL IMMUNOLOGY (2011)
Osteoporosis in inflammatory joint diseases
C. Roux
OSTEOPOROSIS INTERNATIONAL (2011)
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Asiri R. Wijenayaka et al.
PLOS ONE (2011)
The Emerging Role of Dickkopf-1 in Bone Biology: Is It the Main Switch Controlling Bone and Joint Remodeling?
Dimitrios Daoussis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells
Satoshi Kitami et al.
BIOCHIMIE (2010)
Matrix Protein Biglycan Induces Osteoblast Differentiation through Extracellular Signal-Regulated Kinase and Smad Pathways
Xiaoyan Wang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytes
Se Hwan Mun et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis
Benoit Le Goff et al.
JOINT BONE SPINE (2010)
The multiple faces of autoimmune-mediated bone loss
Georg Schett et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus
Kamini Shah et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Frequency and Phenotype of Peripheral Blood Th17 Cells in Ankylosing Spondylitis and Rheumatoid Arthritis
Hui Shen et al.
ARTHRITIS AND RHEUMATISM (2009)
Inhibition of Interleukin-33 Signaling Attenuates the Severity of Experimental Arthritis
Gaby Palmer et al.
ARTHRITIS AND RHEUMATISM (2009)
IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling
H. Huang et al.
CELL DEATH AND DIFFERENTIATION (2009)
Oxidized lipids enhance RANKL production by T lymphocytes: Implications for lipid-induced bone loss
Lucia S. Graham et al.
CLINICAL IMMUNOLOGY (2009)
IL-17 Induces Osteoclastogenesis From Human Monocytes Alone in the Absence of Osteoblasts, Which Is Potently Inhibited by Anti-TNF-α Antibody: A Novel Mechanism of Osteoclastogenesis by IL-17
Toru Yago et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Bone loss in inflammatory disorders
R. Hardy et al.
JOURNAL OF ENDOCRINOLOGY (2009)
The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells
Oliver Dienz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
IL-17 Induces Monocyte Migration in Rheumatoid Arthritis
Shiva Shahrara et al.
JOURNAL OF IMMUNOLOGY (2009)
Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
Agnes Doreau et al.
NATURE IMMUNOLOGY (2009)
Osteoimmunology and the effects of the immune system on bone
Hiroshi Takayanagi
NATURE REVIEWS RHEUMATOLOGY (2009)
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Andreas Leibbrandt et al.
YEAR IN IMMUNOLOGY 2008 (2008)
OSCAR, a key co-stimulation molecule for osteoclasts, is induced in patients with rheumatoid arthritis
Sonja Herman et al.
BONE (2008)
Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity
Chun Kwok Wong et al.
CLINICAL IMMUNOLOGY (2008)
Structure-function relationships in the IL-17 receptor: Implications for signal transduction and therapy
Fang Shen et al.
CYTOKINE (2008)
Regulation of gut inflammation and Th17 cell response by interleukin-21
Daniele Fina et al.
GASTROENTEROLOGY (2008)
Pathophysiology of ankylosing spondylitis: What's new?
Thao Pham
JOINT BONE SPINE (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17
M. Hashizume et al.
RHEUMATOLOGY (2008)
Intracellular and surface RANKL are differentially regulated in patients with ankylosing spondylitis
Daniela Stupphann et al.
RHEUMATOLOGY INTERNATIONAL (2008)
The role of tumor necrosis factor-alpha in systemic lupus erythematosus
Martin Aringer et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice
Hui-Chen Hsu et al.
NATURE IMMUNOLOGY (2008)
Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy
Pal Miheller et al.
INFLAMMATORY BOWEL DISEASES (2007)
Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus
Hye-Young Chun et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
TNF-induced structural joint damage is mediated by IL-1
Jochen Zwerina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra et al.
NATURE MEDICINE (2007)
IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4(+)CD25(+) T cell regulatory functions
Suigui Wan et al.
JOURNAL OF IMMUNOLOGY (2007)
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction
Kojiro Sato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis:: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases
R. J. Francois et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab - Results from the ASPIRE trial
JS Smolen et al.
ARTHRITIS AND RHEUMATISM (2006)
Epidemiology, etiology, and diagnosis of osteoporosis
NE Lane
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis
PKK Wong et al.
ARTHRITIS AND RHEUMATISM (2006)
Type I interferon in systemic lupus erythematosus and other autoimmune diseases
Jacques Banchereau et al.
IMMUNITY (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody:: a prospective open-label pilot study
U Lange et al.
RHEUMATOLOGY (2005)
RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis
M Stolina et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression
T Gaur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
TAZ, a transcriptional modulator of mesenchymal stem cell differentiation
JH Hong et al.
SCIENCE (2005)
Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1
MI Koenders et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss
AR Moschen et al.
GUT (2005)
Cytokines link osteoblasts and inflammation:: microarray analysis of interleukin-17-and TNF-α-induced genes in bone cells
F Shen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Interleukin-21 enhances T-helper cell type 1 signaling and interferon-γ production in Crohn's disease
G Monteleone et al.
GASTROENTEROLOGY (2005)
IL-1 mediates TNF-induced osteoclastogenesis
S Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease
N Franchimont et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Interferon-α in systemic lupus erythematosus
MK Crow et al.
CURRENT OPINION IN RHEUMATOLOGY (2004)
Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment
MJ Ruddy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappa B- and PI3-kinase/Akt-dependent pathways
SY Hwang et al.
ARTHRITIS RESEARCH & THERAPY (2004)
TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis
N Saidenberg-Kermanac'h et al.
BONE (2004)
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor α/tumor necrosis factor receptor system in systemic lupus erythematosus
E Svenungsson et al.
ARTHRITIS AND RHEUMATISM (2003)
Genetic regulation of osteoclast development and function
SL Teitelbaum et al.
NATURE REVIEWS GENETICS (2003)
Control of osteoblast function and regulation of bone mass
S Harada et al.
NATURE (2003)
Interleukin-17 in rheumatoid arthritis - If T cells were to contribute to inflammation and destruction through synergy
P Miossec
ARTHRITIS AND RHEUMATISM (2003)
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-κB ligand/osteoprotegerin balance
E Lubberts et al.
JOURNAL OF IMMUNOLOGY (2003)
IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor κB ligand and tumor necrosis factor a from T cells
G Toraldo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease
E Svenungsson et al.
LUPUS (2003)
Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis
D Hürlimann et al.
CIRCULATION (2002)
Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines
PJ Koshy et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation
K Nakashima et al.
CELL (2002)
The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera
H Matsuno et al.
RHEUMATOLOGY (2002)
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin
K Redlich et al.
ARTHRITIS AND RHEUMATISM (2002)
Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein
KA Bush et al.
ARTHRITIS AND RHEUMATISM (2002)
Enhancing effect of IL-1, IL-17, and TNF-α on macrophage inflammatory protein-3α production in rheumatoid arthritis:: Regulation by soluble receptors and Th2 cytokines
M Chabaud et al.
JOURNAL OF IMMUNOLOGY (2001)
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint
DR Haynes et al.
RHEUMATOLOGY (2001)
LDL-receptor-related protein 6 is a receptor for Dickkopf proteins
BY Mao et al.
NATURE (2001)
Tumor necrosis factor-α (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways
YH Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
J Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis
M Chabaud et al.
CYTOKINE (2000)
Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
R Horai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
